scispace - formally typeset
Journal ArticleDOI

Distinct Sets of Genetic Alterations in Melanoma

TLDR
The genetic alterations identified in melanoma at different sites and with different levels of sun exposure indicate that there are distinct genetic pathways in the development of melanoma and implicate CDK4 and CCND1 as independent oncogenes in melanomas without mutations in BRAF or N-RAS.
Abstract
Background Exposure to ultraviolet light is a major causative factor in melanoma, although the relationship between risk and exposure is complex. We hypothesized that the clinical heterogeneity is explained by genetically distinct types of melanoma with different susceptibility to ultraviolet light. Methods We compared genome-wide alterations in the number of copies of DNA and mutational status of BRAF and N-RAS in 126 melanomas from four groups in which the degree of exposure to ultraviolet light differs: 30 melanomas from skin with chronic sun-induced damage and 40 melanomas from skin without such damage; 36 melanomas from palms, soles, and subungual (acral) sites; and 20 mucosal melanomas. Results We found significant differences in the frequencies of regional changes in the number of copies of DNA and mutation frequencies in BRAF among the four groups of melanomas. Samples could be correctly classified into the four groups with 70 percent accuracy on the basis of the changes in the number of copies of...

read more

Citations
More filters
Journal ArticleDOI

Mutation landscape in melanoma patients clinical implications of heterogeneity of BRAF mutations

TL;DR: As heterogeneity with respect to BRAF mutation status is detected in melanoma patients, subsequent testing of initially wild-type patients can yield different results and thus make BRAF inhibitor therapy accessible, and the role of heterogeneity in testing and for clinical response to therapy with a BRAF inhibitors needs to be further investigated.
Journal ArticleDOI

Cutaneous Toxic Effects Associated With Vemurafenib and Inhibition of the BRAF Pathway

TL;DR: 3 cases are presented that highlight the development of squamous cell carcinomas and other cutaneous sequelae that have not been previously reported and are reminiscent of those observed with administration of the multikinase inhibitor sorafenib tosylate.
Journal ArticleDOI

A Phase II Trial of Sorafenib in Metastatic Melanoma with Tissue Correlates

TL;DR: Sorafenib monotherapy has limited activity in advanced melanoma patients and BRAFV600E mutational status of the tumor was not associated with clinical activity and no significant effect of sorAFenib on cyclin D1 or Ki67 was seen, suggesting that sorafenIB is not an effective BRAF inhibitor or that additional signaling pathways are equally important in the patients who benefit from sorafinib.
Journal ArticleDOI

Role of UV in cutaneous melanoma.

TL;DR: The dual role of the melanin pigment as a photoprotector as well as a photosensitizer is evaluated and the evidence for association between melanin levels (constitutive and induced) and melanoma risk is examined.
References
More filters
Journal ArticleDOI

R: A Language for Data Analysis and Graphics

TL;DR: In this article, the authors discuss their experience designing and implementing a statistical computing language, which combines what they felt were useful features from two existing computer languages, and they feel that the new language provides advantages in the areas of portability, computational efficiency, memory management, and scope.
Journal ArticleDOI

A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4

TL;DR: P16 seems to act in a regulatory feedback circuit with CDK4, D-type cyclins and retinoblastoma protein, and inhibits the catalytic activity of theCDK4/cyclin D enzymes.
Journal ArticleDOI

Comparison of discrimination methods for the classification of tumors using gene expression data

TL;DR: Different discrimination methods for the classification of tumors based on gene expression data include nearest-neighbor classifiers, linear discriminant analysis, and classification trees, which are applied to datasets from three recently published cancer gene expression studies.
Related Papers (5)